Efficacy and Safety of Abrocitinib Versus Dupilumab in Patients Who Self-Identified As Having Skin of Color: A Post Hoc Analysis of JADE COMPARE. J of Skin 2026, 10 (2), s733. https://doi.org/10.25251/8r6ert44.